Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance.
Chang KY, Tsai SY, Chen SH, Tsou HH, Yen CJ, Liu KJ, Fang HL, Wu HC, Chuang BF, Chou SW, Tang CK, Liu SY, Lu PJ, Yen CY, Chang JY.
Chang KY, et al. Among authors: tsai sy.
J Biomed Sci. 2013 Jun 27;20(1):43. doi: 10.1186/1423-0127-20-43.
J Biomed Sci. 2013.
PMID: 23806066
Free PMC article.